Myovant leans on new partner Pfizer as it dives into first launch for cancer drug Orgovyx

Retrieved on: 2021-01-25 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Myovant leans on new partner Pfizer as it dives into first launch for cancer drug Orgovyx. View article details on hiswai:

Excerpt

Myovant Sciences is sporting a new look for 2021: first drug launch, new CEO and a big-time partnership with Pfizer. The Swiss company's prostate ...

Article found on: www.fiercepharma.com